» Articles » PMID: 33688009

Insulinase-like Protease 1 Contributes to Macrogamont Formation in Cryptosporidium Parvum

Overview
Journal mBio
Specialty Microbiology
Date 2021 Mar 10
PMID 33688009
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The apicomplexan parasite contains an expanded family of 22 insulinase-like proteases (INS), a feature that contrasts with their otherwise streamlined genome. Here, we examined the function of INS1, which is most similar to the human insulinase protease that cleaves a variety of small peptide substrates. INS1 is an M16A clan member and contains a signal peptide, an N-terminal domain with the HXXEH active site, followed by three inactive domains. Unlike previously studied INS proteins that are expressed in sporozoites and during merogony, INS1 was expressed exclusively in macrogamonts, where it was localized in small cytoplasmic vesicles. Although INS1 did not colocalize with the oocyst wall protein recognized by the antibody OW50, immune-electron microscopy indicated that INS1 resides in small vesicles in the secretory system. Notably, these small INS1-positive vesicles were often in close proximity to large OW50-positive vacuoles resembling wall-forming bodies, which contain precursors for oocyst wall formation. Genetic deletion of INS1, or replacement with an active-site mutant, resulted in lower formation of macrogamonts and reduced oocyst shedding Our findings reveal that INS1 functions in the formation or maturation of macrogamonts and that its loss results in attenuated virulence in immunocompromised mice. Cryptosporidiosis is a debilitating diarrheal disease in young children in developing countries. The absence of effective treatments or vaccines makes this infection very difficult to manage in susceptible populations. Although the oral dose of oocysts needed to cause infection is low, infected individuals shed very high numbers of oocysts, readily contaminating the environment. Our studies demonstrate that the protease INS1 is important for formation of female sexual stages and that in its absence, parasites produce fewer oocysts and are attenuated in immunocompromised mice. These findings suggest that mutants lacking INS1, or related proteases, are useful for further characterizing the pathway that leads to macrogamont maturation and oocyst wall formation.

Citing Articles

Stage-specific expression and divergent functions of two insulinase-like proteases associated with host infectivity in Cryptosporidium.

Huang Y, Pei S, Lv X, Yang F, Gong X, Li N PLoS Negl Trop Dis. 2025; 19(1):e0012777.

PMID: 39804945 PMC: 11760560. DOI: 10.1371/journal.pntd.0012777.


Function of the alternative electron transport chain in the mitosome.

Deng S, Sibley L bioRxiv. 2024; .

PMID: 39605695 PMC: 11601642. DOI: 10.1101/2024.10.01.616074.


Characterization of NFDQ1 in Cryptosporidium parvum.

Ao Y, Gong X, Li J, Zhao R, Song S, Guo Y Parasit Vectors. 2024; 17(1):439.

PMID: 39462401 PMC: 11514877. DOI: 10.1186/s13071-024-06532-x.


Involvement of INS15 in the development and pathogenicity of the zoonotic pathogen Cryptosporidium parvum.

He W, Cui H, Li N, Guo Y, Zeng S, Feng Y PLoS Negl Trop Dis. 2024; 18(10):e0012569.

PMID: 39361715 PMC: 11478815. DOI: 10.1371/journal.pntd.0012569.


Variant surface protein GP60 contributes to host infectivity of Cryptosporidium parvum.

Li M, Yang F, Hou T, Gong X, Li N, Sibley L Commun Biol. 2024; 7(1):1175.

PMID: 39294220 PMC: 11411101. DOI: 10.1038/s42003-024-06885-0.


References
1.
Aleshin A, Gramatikova S, Hura G, Bobkov A, Strongin A, Stec B . Crystal and solution structures of a prokaryotic M16B peptidase: an open and shut case. Structure. 2009; 17(11):1465-75. PMC: 3615642. DOI: 10.1016/j.str.2009.09.009. View

2.
Perlman R, Gehm B, Kuo W, Rosner M . Functional analysis of conserved residues in the active site of insulin-degrading enzyme. J Biol Chem. 1993; 268(29):21538-44. View

3.
Checkley W, White Jr A, Jaganath D, Arrowood M, Chalmers R, Chen X . A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. Lancet Infect Dis. 2014; 15(1):85-94. PMC: 4401121. DOI: 10.1016/S1473-3099(14)70772-8. View

4.
Xu Z, Guo Y, Roellig D, Feng Y, Xiao L . Comparative analysis reveals conservation in genome organization among intestinal Cryptosporidium species and sequence divergence in potential secreted pathogenesis determinants among major human-infecting species. BMC Genomics. 2019; 20(1):406. PMC: 6532270. DOI: 10.1186/s12864-019-5788-9. View

5.
Wilke G, Funkhouser-Jones L, Wang Y, Ravindran S, Wang Q, Beatty W . A Stem-Cell-Derived Platform Enables Complete Cryptosporidium Development In Vitro and Genetic Tractability. Cell Host Microbe. 2019; 26(1):123-134.e8. PMC: 6617391. DOI: 10.1016/j.chom.2019.05.007. View